Economic cost of Guillain-Barré syndrome in the United States

摘要: Objective This study estimated the annual economic cost of Guillain-Barre syndrome (GBS) in United States 2004, including direct costs medical care and indirect due to lost productivity premature death. Methods The cost-of-illness method was used determine productivity, a modified value statistical life approach deaths. Data were obtained from Nationwide Inpatient Sample, Medical Expenditure Panel Survey, Compressed Mortality File, telephone survey 180 adult patients with GBS, other sources. Results GBS $1.7 billion (95% CI, $1.6 1.9 billion), $0.2 (14%) $1.5 (86%) costs. Most for community hospital admissions. mean per patient $318,966 $278,378 359,554). Conclusions substantial, largely disability estimate summarizes lifetime health burden monetary terms, provides some information needed assess cost-effectiveness measures that affect GBS.